Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E) (EGX:RMDA)

EGX:RMDA Balance Sheet

Financials in millions EGP. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	36.18	64.69	52.36	66.96	14
Short-Term Investments	-	189.7	260.9	361.86	468.01
Cash & Short-Term Investments	36.18	254.39	313.25	428.82	482.01
Cash Growth	-85.78%	-18.79%	-26.95%	-11.04%	-0.12%
Accounts Receivable	1,027	791.26	353.74	276.6	265.96
Other Receivables	62.48	103.43	72.16	22.6	25.2
Receivables	2,178	1,582	1,344	923.28	684.61
Inventory	1,031	751.34	303.26	348.41	259.4
Prepaid Expenses	10.49	4.29	2.21	2.83	0.99
Other Current Assets	178.67	544.65	60.33	55.14	48.64
Total Current Assets	3,435	3,137	2,023	1,758	1,476
Property, Plant & Equipment	792.15	621.52	606.05	556.98	554.99
Other Intangible Assets	1,111	552.79	589.27	457.57	389.66
Total Assets	5,338	4,311	3,218	2,773	2,420
Accounts Payable	335.19	264.36	102.41	120.25	61.53
Accrued Expenses	154.76	115.09	76.44	62.92	37.31
Short-Term Debt	2,326	1,555	1,098	910.18	842.6
Current Portion of Long-Term Debt	-	-	-	-	21.95
Current Portion of Leases	6.76	4.48	4.81	3.66	3.13
Current Income Taxes Payable	116.58	98.78	60.59	53.71	33.49
Other Current Liabilities	43.98	117.77	30.67	31.23	22.05
Total Current Liabilities	2,984	2,155	1,373	1,182	1,022
Long-Term Leases	75.46	7.19	11.7	16.34	12.26
Long-Term Deferred Tax Liabilities	68.57	77.28	58.23	51.56	40.5
Total Liabilities	3,128	2,240	1,443	1,250	1,075
Common Stock	500	378.23	375	250	250
Additional Paid-In Capital	255.79	327.51	377.7	397.52	486.97
Retained Earnings	1,399	1,351	1,022	921.68	610.87
Treasury Stock	-	-26.23	-26.23	-65.93	-
Comprehensive Income & Other	13.04	13.31	14.21	15.31	0.28
Total Common Equity	2,168	2,044	1,763	1,519	1,348
Minority Interest	42.12	27.38	12.94	4.59	-2.62
Shareholders' Equity	2,210	2,072	1,775	1,523	1,345
Total Liabilities & Equity	5,338	4,311	3,218	2,773	2,420
Total Debt	2,409	1,566	1,114	930.18	879.94
Net Cash (Debt)	-2,372	-1,312	-801.18	-501.37	-397.93
Net Cash Per Share	-1.18	-0.65	-0.40	-0.26	-0.20
Filing Date Shares Outstanding	2,000	1,990	1,973	1,973	2,015
Total Common Shares Outstanding	2,000	1,990	1,973	1,956	2,015
Working Capital	450.99	981.82	650.11	576.53	453.59
Book Value Per Share	1.08	1.03	0.89	0.78	0.67
Tangible Book Value	1,057	1,491	1,173	1,061	958.45
Tangible Book Value Per Share	0.53	0.75	0.59	0.54	0.48
Land	18.64	18.64	18.64	18.64	18.64
Buildings	300.43	294.77	288.43	279.17	273.34
Machinery	726.8	646.31	585.04	533.6	491.55
Construction In Progress	94.15	33.46	38.09	12.86	27.04

Source: S&P Global Market Intelligence. Standard template. Financial Sources.